Mikan George Lawrence III's Form 4 filing
NeueHealth, Inc. (NEUE) · filed Dec 18, 2024
- Accession no.
- 0001628280-24-051940
- Filed
- Dec 18, 2024
- Trade date
- Dec 14-17, 2024
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $70.2K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mikan George Lawrence IIICIK 0001381037 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2024 | Common Stock | MOption exerciseAcquired | +35,000 | – | – | 99,832 | Direct | |
| Dec 17, 2024 | Common Stock | SSaleDisposed | −16,803 | $4.18 | −$70,236.54 | 83,029 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2024 | Common Stock | MOption exerciseDisposed | −35,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.